Short answer
Paysign, Inc. (PAYS) filed its Q2 2026 10-Q quarterly report on Aug 6, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $28M (up 48.1% year over year) with net income of $7M.
Q2 2026 key financials · XBRL
- Revenue
- $28M
- +48.1% YoY · +0.8% QoQ
- Net income
- $7M
- +386.9% YoY · +24.2% QoQ
- Operating margin
- 24.8%
- Gross margin
- 63.3%
- EPS (diluted)
- $0.11
- +450.0% YoY · +22.2% QoQ
Source: XBRL data from the Paysign, Inc. (PAYS) Q2 2026 10-Q on SEC EDGAR. USD.
Paysign, Inc. Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $28.3M, up 48.1% YoY from $19.1M
- Pharma revenue $14.6M, up 88.9% YoY, best-performing segment
- Plasma revenue $13.0M, up 21.4% YoY; other revenue $562,398, down 3.1%
- Gross margin 63.3% vs 61.6% YoY; net margin 23.9% vs 7.3%
- 2026 investments in technology, sales, cybersecurity, fraud, customer service and regulatory compliance; potential capital raising for new markets
Risk Factors
- Risk-factor disclosure omitted because Paysign qualifies as a smaller reporting company
- Newly authorized $5 million stock-repurchase program expiring May 7, 2029
- No unregistered common-stock issuances during quarter ended June 30, 2026
- No director or officer adopted or terminated trading arrangements during the quarter
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Paysign, Inc. quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.